Clinical Trial Update: Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial evaluating comprehensive genomic profiling in tissue samples from patients with recurrent or stage IV non-small cell lung cancer. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | NA | Status: RECRUITING